HyTdb

JQ-HyT

HyT-055 | Adamantane | Published 2025.06.23

Basic Information

JQ1
Linker
Adamantane
POIBRD4 — Bromodomain-containing protein 4(BRD4)
Degradation Pathway
Published2025.06.23

Remarks

Chemical Identifiers

SMILESCC1=C(C)SC2=C1C(C3=CC=C(C=C3)Cl)=NC(CC(NCCOCCOCCOCCNC(CC45C[C@H](C[C@@H]6C5)C[C@H](C6)C4)=O)=O)C7=NN=C(C)N27
Molecular FormulaC39H51ClN6O5S
InChIInChI=1S/C39H51ClN6O5S/c1-24-25(2)52-38-35(24)36(30-4-6-31(40)7-5-30)43-32(37-45-44-26(3)46(37)38)19-33(47)41-8-10-49-12-14-51-15-13-50-11-9-42-34(48)23-39-20-27-16-28(21-39)18-29(17-27)22-39/h4-7,27-29,32H,8-23H2,1-3H3,(H,41,47)(H,42,48)
InChI KeyMBGVXHVZXWTXEY-UHFFFAOYSA-N
IUPAC NameNA
PubChem CIDNA

Basic Properties

TPSAComputing…
RingsComputing…
FSP3Computing…
Heavy Atom CountComputing…

Lipinski RO5

RO5 ViolationComputing…
MWComputing…
ClogPComputing…
HBDComputing…
HBAComputing…
RBComputing…

Hydrophobic Tag Properties

Tag Structure
Tag TypeAdamantane
Tag SMILESC1(CC2C3)CC(C2)CC3C1
Tag ClogP5.022
HydrophobicityHigh(ClopP>5)

Mechanism of Action

POI (Protein of Interest)

POI NameBromodomain-containing protein 4(BRD4)
GeneBRD4
UniProt IDO60885

Amino Acid Sequence

MSAESGPGTRLRNLPVMGDGLETSQMSTTQAQAQPQPANAASTNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETEIMIVQAKGRGRGRKETGTAKPGVSTVPNTTQASTPPQTQTPQPNPPPVQATPHPFPAVTPDLIVQTPVMTVVPPQPLQTPPPVPPQPQPPPAPAPQPVQSHPPIIAATPQPVKTKKGVKRKADTTTPTTIDPIHEPPSLPPEPKTTKLGQRRESSRPVKPPKKDVPDSQQHPAPEKSSKVSEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMPDEPEEPVVAVSSPAVPPPTKVVAPPSSSDSSSDSSSDSDSSTDDSEEERAQRLAELQEQLKAVHEQLAALSQPQQNKPKKKEKDKKEKKKEKHKRKEEVEENKKSKAKEPPPKKTKKNNSSNSNVSKKEPAPMKSKPPPTYESEEEDKCKPMSYEEKRQLSLDINKLPGEKLGRVVHIIQSREPSLKNSNPDEIEIDFETLKPSTLRELERYVTSCLRKKRKPQAEKVDVIAGSSKMKGFSSSESESSSESSSSDSEDSETEMAPKSKKKGHPGREQKKHHHHHHQQMQQAPAPVPQQPPPPPQQPPPPPPPQQQQQPPPPPPPPSMPQQAAPAMKSSPPPFIATQVPVLEPQLPGSVFDPIGHFTQPILHLPQPELPPHLPQPPEHSTPPHLNQHAVVSPPALHNALPQQPSRPSNRAAALPPKPARPPAVSPALTQTPLLPQPPMAQPPQVLLEDEEPPAPPLTSMQMQLYLQQLQKVQPPTPLLPSVKVQSQPPPPLPPPPHPSVQQQLQQQPPPPPPPQPQPPPQQQHQPPPRPVHLQPMQFSTHIQQPPPPQGQQPPHPPPGQQPPPPQPAKPQQVIQHHHSPRHHKSDPYSTGHLREAPSPLMIHSPQMSQFQSLTHQSPPQQNVQPKKQELRAASVVQPQPLVVVKEEKIHSPIIRSEPFSPSLRPEPPKHPESIKAPVHLPQRPEMKPVDVGRPVIRPPEQNAPPPGAPDKDKQKQEPKTPVAPKKDLKIKNMGSWASLVQKHPTTPSSTAKSSSDSFEQFRRAAREKEEREKALKAQAEHAEKEKERLRQERMRSREDEDALEQARRAHEEARRRQEQQQQQRQEQQQQQQQQAAAVAAAATPQAQSSQPQSMLDQQRELARKREQERRRREAMAATIDMNFQSDLLSIFEENLF

3D Structure (/structures/AF-O60885-F1-model_v6.cif)

Loading /structures/AF-O60885-F1-model_v6.cif …

Function

Chromatin reader protein that recognizes and binds acetylated histones and plays a key role in transmission of epigenetic memory across cell divisions and transcription regulation. Remains associated with acetylated chromatin throughout the entire cell cycle and provides epigenetic memory for postmitotic G1 gene transcription by preserving acetylated chromatin status and maintaining high-order chromatin structure. During interphase, plays a key role in regulating the transcription of signal-inducible genes by associating with the P-TEFb complex and recruiting it to promoters. Also recruits P-TEFb complex to distal enhancers, so called anti-pause enhancers in collaboration with JMJD6. BRD4 and JMJD6 are required to form the transcriptionally active P-TEFb complex by displacing negative regulators such as HEXIM1 and 7SKsnRNA complex from P-TEFb, thereby transforming it into an active form that can then phosphorylate the C-terminal domain (CTD) of RNA polymerase II. Regulates differentiation of naive CD4+ T-cells into T-helper Th17 by promoting recruitment of P-TEFb to promoters. Promotes phosphorylation of 'Ser-2' of the C-terminal domain (CTD) of RNA polymerase II. According to a report, directly acts as an atypical protein kinase and mediates phosphorylation of 'Ser-2' of the C-terminal domain (CTD) of RNA polymerase II; these data however need additional evidences in vivo. In addition to acetylated histones, also recognizes and binds acetylated RELA, leading to further recruitment of the P-TEFb complex and subsequent activation of NF-kappa-B. Also acts as a regulator of p53/TP53-mediated transcription: following phosphorylation by CK2, recruited to p53/TP53 specific target promoters.

Degradation Pathway

Activity Data

TypeIC50
Value2.25±0.36(37℃)μM;0.59±0.06(45℃)μM
POI NameBRD4
Cell LineCT26
Cell Line IDCVCL_7254
Assay MethodMTT assay
Reference10.1002/smll.202504000

Description

Additionally, the IC50 curve depicted in Figure 1E exhibited a leftward shift, with IC50 values decreasing by 73.8%, indicating an enhanced cellular inhibitory effect of HyT at elevated temperatures. The introduction of HyT significantly reduced cell viability after heat incubation, as shown in Figure 1F. When the concentration of JQ-HyT was raised from 0.5 to 1.0 m Mtransmission electron microscope, thermal cytotoxicity increased by 44.7%, indicating that JQ-HyT amplifies thermal toxicity. E, F) Viabilities of CT26 cells treated by JQ-HyT with or without thermal treatment (45°C, 30 min) for 24 h (n =6).

Disease Information

DiseaseICD-11Source
Cornelia De Lange SyndromeLD2F.1YGene-Disease Association
Nut Midline CarcinomaXH2855Gene-Disease Association
Borjeson-Forssman-Lehmann SyndromeLD29Gene-Disease Association
Ewing SarcomaXH8KJ8Gene-Disease Association